MoneyWorks4Me

Relisys Medical Devices informs about standalone financial results

11 Dec 2017 Evaluate

Relisys Medical Devices has informed about Standalone Financial Results and Limited Review for the period ended September 30, 2017; disclosure as per Regulation 52(4) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015; and submission of Statement of Material Deviations as per Regulation 52(7) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The above information is a part of company’s filings submitted to BSE.

Peers